Design Therapeutics, Inc. DSGN Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s invested capital?
- Design Therapeutics, Inc. (DSGN) reported invested capital of $208.02M in Q1 2026.
- How has Design Therapeutics, Inc.'s invested capital changed year-over-year?
- Design Therapeutics, Inc.'s invested capital decreased by 3.9% year-over-year, from $216.39M to $208.02M.
- What is the long-term trend for Design Therapeutics, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s invested capital has grown at a 22.6% compound annual growth rate (CAGR), from $87.19M to $197.18M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).